Grail (NASDAQ:GRAL) Reaches New 1-Year High – Time to Buy?

Grail, Inc. (NASDAQ:GRAL)’s share price hit a new 52-week high during trading on Thursday . The stock traded as high as $25.35 and last traded at $25.28, with a volume of 817260 shares changing hands. The stock had previously closed at $22.64.

Analysts Set New Price Targets

GRAL has been the topic of several recent research reports. Wolfe Research initiated coverage on Grail in a research report on Friday, November 15th. They set a “peer perform” rating on the stock. Morgan Stanley assumed coverage on Grail in a research report on Wednesday, November 27th. They set an “equal weight” rating and a $16.00 price objective on the stock. Finally, Guggenheim assumed coverage on Grail in a research report on Thursday, October 17th. They set a “neutral” rating on the stock.

Grail Stock Up 14.7 %

The company’s 50 day moving average is $18.57.

Grail (NASDAQ:GRAL) last posted its earnings results on Tuesday, November 12th. The company reported ($3.94) earnings per share (EPS) for the quarter. The firm had revenue of $28.65 million during the quarter. As a group, analysts anticipate that Grail, Inc. will post -65.16 EPS for the current fiscal year.

Insider Activity at Grail

In other Grail news, CFO Aaron Freidin sold 30,452 shares of the business’s stock in a transaction on Monday, November 18th. The stock was sold at an average price of $14.02, for a total value of $426,937.04. Following the sale, the chief financial officer now directly owns 268,277 shares of the company’s stock, valued at approximately $3,761,243.54. The trade was a 10.19 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of GRAL. FNY Investment Advisers LLC bought a new position in shares of Grail during the fourth quarter valued at $26,000. Perigon Wealth Management LLC purchased a new stake in Grail during the fourth quarter valued at $260,000. B & T Capital Management DBA Alpha Capital Management purchased a new stake in Grail during the fourth quarter valued at $387,000. A. D. Beadell Investment Counsel Inc. purchased a new stake in Grail during the fourth quarter valued at $430,000. Finally, Exchange Traded Concepts LLC purchased a new stake in Grail during the fourth quarter valued at $507,000.

Grail Company Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.